# Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function

> **NCT00626249** · PHASE1 · COMPLETED · sponsor: **Mannkind Corporation** · enrollment: 36 (actual)

## Conditions studied

- Mild Nephropathy
- Moderate Nephropathy
- Diabetes Mellitus

## Interventions

- **DRUG:** Technosphere Inhalation Powder

## Key facts

- **NCT ID:** NCT00626249
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-09
- **Final completion:** 2008-10
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2013-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00626249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00626249, "Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00626249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*